Notably, group C contained a significantly higher percentage of patients with CAD than did in group A and B. The patients took the following medications; 145, antiplatelet agents; 83, angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers; 133, beta-adrenoreceptor blockers; 76, statin. Here, ACE is linked to coronary artery disorder.